Nu Skin Enterprises, Inc.

NUS

US67018T1051

Personal Products

Market Closed - Nyse Other stock markets 04:00:02 2024-05-13 pm EDT			5-day change	1st Jan Change
13.51 ^USD	+2.19%		+10.74%	-30.43%

May. 09	DA Davidson Adjusts Nu Skin Enterprises' Price Target to $12.50 From $15.50, Keeps Neutral Rating	MT
May. 08	Transcript : Nu Skin Enterprises, Inc., Q1 2024 Earnings Call, May 08, 2024

Nu Skin Enterprises, Inc.(NYSE:NUS) added to Russell 3000 Growth Index

June 25, 2021 at 12:00 am EDT

Latest news about Nu Skin Enterprises, Inc.

DA Davidson Adjusts Nu Skin Enterprises' Price Target to $12.50 From $15.50, Keeps Neutral Rating	May. 09	MT
Transcript : Nu Skin Enterprises, Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
(NUS) NU SKIN ENTERPRISES Expects Q2 EPS Range $0.10 - $0.20	May. 08	MT
Earnings Flash (NUS) NU SKIN ENTERPRISES Posts Q1 Revenue $417.3M, vs. Street Est of $432.4M	May. 08	MT
Earnings Flash (NUS) NU SKIN ENTERPRISES Posts Q1 EPS $0.09, vs. Street Est of $0.05	May. 08	MT
Nu Skin Enterprises, Inc. Provides Earnings Guidance for the Second Quarter of 2024	May. 08	CI
Nu Skin Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on June 12, 2024	May. 08	CI
Nu Skin Enterprises, Inc. Announces Retirement of Andrew Lipman as Board of Directors	Mar. 18	CI
Sector Update: Consumer Stocks Advance Premarket Thursday	Feb. 15	MT
US Equity Futures Remain Little Changed Pre-Bell as Weekly Jobless Claims Drop	Feb. 15	MT
Top Premarket Decliners	Feb. 15	MT
Nu Skin Enterprises' Q4 Adjusted Earnings, Revenue Decline; Quarterly Dividend Cut -- Shares Slump Pre-Bell	Feb. 15	MT
Transcript : Nu Skin Enterprises, Inc., Q4 2023 Earnings Call, Feb 14, 2024	Feb. 14
Tranche Update on Nu Skin Enterprises, Inc.'s Equity Buyback Plan announced on August 3, 2018.	Feb. 14	CI
Earnings Flash (NUS) NU SKIN ENTERPRISES Reports Q4 Revenue $488.6M, vs. Street Est of $476.4M	Feb. 14	MT
Earnings Flash (NUS) NU SKIN ENTERPRISES Posts Q4 EPS $0.37, vs. Street Est of $0.28	Feb. 14	MT
Nu Skin Enterprises, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	Feb. 14	CI
Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024	Feb. 14	CI
Nu Skin Enterprises, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 14	CI
Nu Skin Enterprises, Inc. Approves and Adopts the Fifth Amended and Restated Bylaws	Feb. 06	CI
Transcript : Nu Skin Enterprises, Inc. Presents at 26th Annual ICR Conference, Jan-08-2024 through Jan-10-2024	Jan. 09
Nu Skin Opens New Production Facility in Shanghai	Nov. 29	MT
Nu Skin Enterprises, Inc. Opens New Manufacturing Facility in Shanghai, China	Nov. 29	CI
Nu Skin Enterprises Insider Sold Shares Worth $272,272, According to a Recent SEC Filing	Nov. 06	MT

Chart Nu Skin Enterprises, Inc.

Duration

Period

More charts

Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Companyâs Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.

Sector

Personal Products

Calendar

2024-06-04 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Nu Skin Enterprises, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

13.51 USD

Average target price

12.83 USD

Spread / Average Target

-5.01%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Personal Products

	1st Jan change	Capi.
NU SKIN ENTERPRISES, INC.	-30.43%	657M
PROCTER & GAMBLE COMPANY	+13.19%	394B
UNILEVER PLC	+13.53%	134B
COLGATE-PALMOLIVE COMPANY	+18.50%	78.02B
HINDUSTAN UNILEVER LIMITED	-11.38%	66.3B
ESTEE LAUDER	-7.89%	47.33B
KENVUE INC.	-5.43%	39.33B
BEIERSDORF	+8.33%	35.5B
ESSITY AB	+12.28%	18.09B
GODREJ CONSUMER PRODUCTS LIMITED	+18.31%	16.17B

Other Personal Products